A Dengue Vaccine
- PMID: 27368091
- DOI: 10.1016/j.cell.2016.06.036
A Dengue Vaccine
Abstract
Denvaxia is the first licensed vaccine for the prevention of dengue. It is a live vaccine developed using recombinant DNA technology. The vaccine is given as three doses over the course of a year and has the potential to prevent hundreds of thousands of hospitalizations each year.
Copyright © 2016. Published by Elsevier Inc.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
